168 related articles for article (PubMed ID: 11574412)
1. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
Nielsen S; Møller N; Christiansen JS; Jørgensen JO
Diabetes; 2001 Oct; 50(10):2301-8. PubMed ID: 11574412
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
[TBL] [Abstract][Full Text] [Related]
3. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
Nielsen S; Møller N; Pedersen SB; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
[TBL] [Abstract][Full Text] [Related]
5. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.
Vestergaard ET; Hansen TK; Nielsen S; Moller N; Christiansen JS; Jorgensen JO
Eur J Endocrinol; 2005 Oct; 153(4):545-9. PubMed ID: 16189176
[TBL] [Abstract][Full Text] [Related]
6. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
Nørrelund H; Nielsen S; Christiansen JS; Jørgensen JO; Møller N
Eur J Endocrinol; 2004 Jun; 150(6):779-87. PubMed ID: 15191347
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2 × 2 factorial, randomised, crossover study in human individuals.
Hjelholt AJ; Charidemou E; Griffin JL; Pedersen SB; Gudiksen A; Pilegaard H; Jessen N; Møller N; Jørgensen JOL
Diabetologia; 2020 Dec; 63(12):2641-2653. PubMed ID: 32945898
[TBL] [Abstract][Full Text] [Related]
8. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
9. Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.
Nielsen S; Jørgensen JO; Hartmund T; Nørrelund H; Nair KS; Christiansen JS; Møller N
Growth Horm IGF Res; 2002 Dec; 12(6):425-33. PubMed ID: 12423628
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients.
Alvarez P; Isidro L; Peinó R; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2003 Oct; 59(4):431-6. PubMed ID: 14510904
[TBL] [Abstract][Full Text] [Related]
11. Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.
Van Dam PS; Smid HE; de Vries WR; Niesink M; Bolscher E; Waasdorp EJ; Dieguez C; Casanueva FF; Koppeschaar HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4706-11. PubMed ID: 11134132
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat.
Vickers MH; Hofman PL; Gluckman PD; Lobie PE; Cutfield WS
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1212-9. PubMed ID: 16803850
[TBL] [Abstract][Full Text] [Related]
13. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
Piatti PM; Monti LD; Caumo A; Conti M; Magni F; Galli-Kienle M; Fochesato E; Pizzini A; Baldi L; Valsecchi G; Pontiroli AE
J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
[TBL] [Abstract][Full Text] [Related]
14. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
Lanzi R; Luzi L; Caumo A; Andreotti AC; Manzoni MF; Malighetti ME; Sereni LP; Pontiroli AE
Metabolism; 1999 Sep; 48(9):1152-6. PubMed ID: 10484056
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
Krag MB; Gormsen LC; Guo Z; Christiansen JS; Jensen MD; Nielsen S; Jørgensen JO
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E920-7. PubMed ID: 17132823
[TBL] [Abstract][Full Text] [Related]
16. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation.
Vestergaard ET; Cichosz SL; Møller N; Jørgensen JOL; Fleischer J
Br J Clin Pharmacol; 2017 Dec; 83(12):2671-2677. PubMed ID: 28736944
[TBL] [Abstract][Full Text] [Related]
17. Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects.
Pontiroli AE; Lanzi R; Monti LD; Pozza G
J Endocrinol Invest; 1990 Jun; 13(6):539-42. PubMed ID: 2258583
[TBL] [Abstract][Full Text] [Related]
18. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
[TBL] [Abstract][Full Text] [Related]
19. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans.
Gormsen LC; Jessen N; Gjedsted J; Gjedde S; Nørrelund H; Lund S; Christiansen JS; Nielsen S; Schmitz O; Møller N
J Clin Endocrinol Metab; 2007 May; 92(5):1834-42. PubMed ID: 17341555
[TBL] [Abstract][Full Text] [Related]
20. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]